Fallbericht
Unraveling hypertension through mineralocorticoid receptor activation in Cushing’s syndrome: A case report
Clinical Nephrology · 2025
DOI: 10.5414/cn111430 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Nephrology, 2025. Verfasst von Holly Thomson und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cushing Syndrome, Hypertension, Receptors, Mineralocorticoid, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Cushing SyndromeHypertensionReceptors, MineralocorticoidLung NeoplasmsHumansMaleMiddle AgedMineralocorticoid Receptor AntagonistsEplerenoneSpironolactoneHydrocortisoneBlood PressureAntihypertensive AgentsTreatment Outcome
Substanzen
Receptors, MineralocorticoidMineralocorticoid Receptor AntagonistsEplerenoneSpironolactoneHydrocortisoneAntihypertensive Agents
Zitieren
APA
Thomson, H., Westphal, S., & Hommos, M. S. (2025). Unraveling hypertension through mineralocorticoid receptor activation in Cushing’s syndrome: A case report. Clinical Nephrology. https://doi.org/10.5414/cn111430
Vancouver
Thomson H, Westphal S, Hommos MS. Unraveling hypertension through mineralocorticoid receptor activation in Cushing’s syndrome: A case report. Clinical Nephrology. 2025. doi:10.5414/cn111430
BibTeX
@article{Thomson2025,
author = {Thomson, Holly and Westphal, Sydney and Hommos, Musab S},
title = {Unraveling hypertension through mineralocorticoid receptor activation in Cushing’s syndrome: A case report},
journal = {Clinical Nephrology},
year = {2025},
doi = {10.5414/cn111430}
}
EUVIMED